Mouse serum factor(s) down-modulate the CD4 and CXCR4 molecules on human T cells conferring resistance to HIV infection in NOG mice

Medical Microbiology and Immunology

Volumn 194, Issue 4, 2005, Pages 175-180

  Dewan, Md Zahidunnabi ^a,b   Terashima, Kazuo ^a   Ahmed, Sunjida ^a   Ohba, Kenji ^a   Taruishi, Midori ^a   Yamamoto, Naoki ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CD4; CXCR4; HIV 1; Mouse serum

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SERUM FACTOR; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; ANTIGENS, CD4; BIOLOGICAL FACTORS; CARRIER PROTEINS; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; RECEPTORS, CXCR4; SERUM; T-LYMPHOCYTES;

EID: 23844535379     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-004-0234-1     Document Type: Article

References (26)

1. Blankson JN, Persaud D, Siliciano RF (2002) The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 53:557-593
2. Butera ST (2000) Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities. Antiviral Res 48:143-176
3. Chun TW, Fauci AS (1999) Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci USA 96:10958-10961
4. Ho DD (1998) Toward HIV eradication or remission: the tasks ahead. Science 280:1866-1867
5. Pomerantz RJ (2002) Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin Infect Dis 34:91-97
6. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 94:13193-13197
7. Chun TW, Davey RT, Ostrowski M Jr, Shawn Justement J, Engel D, Mullins JI, Fauci AS (2000) Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 6:757-761
8. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300
9. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512-517
10. Ramratnam B, Mittler JE, Zhang L, Boden D, Hurley A, Fang F, Macken CA, Perelson AS, Markowitz M, Ho DD (2000) The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 6:82-85
11. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295
12. Zhang L, Chung C, Hu BS, He T, Guo Y, Kim AJ, Skulsky E, Jin X, Hurley A, Ramratnam B, Markowitz M, Ho DD (2000) Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest 106:839-845
13. Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N (1997) Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol 71:2417-2424
14. Brooks DG, Kitchen SG, Kitchen CMR, Scripture-Adams DD, Zack JA (2001) Generation of HIV latency during thymopoiesis. Nat Med 7:459-464
15. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182
16. null mice: suppression by an inhibitor against NF-κB. J Virol 77:5286-5294
17. Dewan MZ, Watanabe M, Terashima K, Aoki M, Sata T, Honda M, Ito M, Yamaoka S, Watanabe T, Horie R, Yamamoto N (2004) Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammac null mice. Cancer Sci 95:564-568
18. Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566
19. Kanno T, Brown K, Franzoso G, Siebenlist U (1994) Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kB. Mol Cell Biol 14:6443
20. Sun S, Elwood J, Beraud C, Greene WC (1994) Human T-cell leukemia virus type I Tax activation of NF-kB/Rel involves phosphoryation and degradation of IkB alpha and RelA (p65)-mediated induction of the c-rel gene. Mol Cell Biol 14:7377-7384
21. Lacoste J, Petropoulos L, Pepin N, Hiscott J (1995) Constitutive phosphorylation and turnover of IkB alpha in human T-cell leukemia virus type I-infected and Tax-expressing T cells. J Virol 69:564-569
22. Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N (1999) Constitutive activation of NF-kB in primary adult T-cell leukemia cells. Blood 93:2360-2368
23. Perkins ND, Agranoff AB, Pascal E, Nabel GJ (1994) An interaction between the DNA-binding domains of RelA (p65) and SpI mediates human immunodeficiency virus gene activation. Mol Cell Biol 14:6570-6583
24. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ (1993) A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J 12:3551-3558
25. Liotta LA (2001) Cancer: an attractive force in metastasis. Nature 410:24-25
26. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56